Neuralert Stroke Monitor Trial

01 Apr 20264 min read0 viewsINTERVENTIONAL Trial

GIST (Key Takeaways)

RECRUITING · INTERVENTIONAL · OTHER study · Surgery · Enrollment 1200 · Sponsor: Neuralert Technologies LLC

Clinical Editorial

ClinicalTrials.gov published a clinical update in Cardiology on 01 Apr 2026. The item focuses on Neuralert Stroke Monitor Trial. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT07362303

Open Original Source More Feed Items

Related by Condition/Drug

AHA NewsRelated by Conditionstroke

Toledo executive leads efforts to improve women's heart health

Cardiology • 09 Jul 2026

AHA NewsRelated by Conditionstroke

Extreme heat is rising — and so is the risk to your heart

Cardiology • 09 Jul 2026

JAHARelated by Conditionstroke

Total Clinical Event Burden With Edoxaban Monotherapy Versus Dual Antithrombotic Therapy in Atrial Fibrillation and Stable Coronary Artery Disease: Insights From the EPIC‐CAD Trial

Cardiology • 08 Jul 2026

JAHARelated by Conditionstroke

Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank

Cardiology • 03 Jul 2026

CirculationRelated by Conditionstroke

Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial

Cardiology • 25 May 2026

ClinicalTrialsRelated by Conditionstroke

Pulmonary Embolism and Right-to-Left Shunts

Cardiology • 09 Apr 2026

Feed Metadata

Source

ClinicalTrials.gov